April 9 (Reuters) - Pacific Biosciences of California Inc PACB.O:
PACBIO ANNOUNCES PRELIMINARY FIRST QUARTER 2025 REVENUE AND REITERATES 2025 REVENUE GUIDANCE OF $155 MILLION TO $170 MILLION
PACIFIC BIOSCIENCES OF CALIFORNIA: GIVEN UNCERTAINTY IN ACADEMIC, NIH FUNDING & NEW TARIFFS, REDUCING SPENDING TO ACHIEVE POSITIVE CASH FLOW BY 2027
Source text: ID:nGNX5DZtbp
Further company coverage: PACB.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.